Clinical Trial Update: Cervical Cancer Screening with NGS-HPV Technology Based on Menstrual Blood

View source ↗

Summary

A clinical trial is recruiting to evaluate cervical cancer screening using NGS-HPV technology based on menstrual blood.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Zhongnan Hospital | Conditions: Cervical Cancer | Status: RECRUITING